Business Description
Rockwell Medical Inc
NAICS : 325412
SIC : 2834
ISIN : US7743743004
Total Employee Number:
157Compare
Compare
Traded in other countries / regions
RMTI.USARWM.Germany Index Membership
Russell 2000 IPO Date
1998-01-27Description
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.78 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | -7.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -7.6 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.7 | |||||
3-Year EBITDA Growth Rate | 63.4 | |||||
3-Year EPS without NRI Growth Rate | 50.7 | |||||
3-Year FCF Growth Rate | 69.7 | |||||
3-Year Book Growth Rate | -6.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.26 | |||||
9-Day RSI | 60.68 | |||||
14-Day RSI | 60.94 | |||||
3-1 Month Momentum % | 8.02 | |||||
6-1 Month Momentum % | -17.57 | |||||
12-1 Month Momentum % | -55.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.25 | |||||
Quick Ratio | 3 | |||||
Cash Ratio | 2.22 | |||||
Days Inventory | 22.27 | |||||
Days Sales Outstanding | 43.85 | |||||
Days Payable | 14.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48 | |||||
Shareholder Yield % | 0.51 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.71 | |||||
Operating Margin % | -6.52 | |||||
Net Margin % | -7.33 | |||||
EBITDA Margin % | -2.68 | |||||
FCF Margin % | 2.22 | |||||
OCF Margin % | 4.18 | |||||
ROE % | -14.5 | |||||
ROA % | -9.04 | |||||
ROIC % | -15.69 | |||||
3-Year ROIIC % | 145.32 | |||||
ROC (Joel Greenblatt) % | -27.51 | |||||
ROCE % | -8.58 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 7.73 | |||||
PS Ratio | 0.45 | |||||
PB Ratio | 0.9 | |||||
Price-to-Tangible-Book | 1.28 | |||||
Price-to-Free-Cash-Flow | 22.62 | |||||
Price-to-Operating-Cash-Flow | 11.4 | |||||
EV-to-EBIT | -5.4 | |||||
EV-to-EBITDA | -11.48 | |||||
EV-to-Revenue | 0.31 | |||||
EV-to-Forward-Revenue | 0.27 | |||||
EV-to-FCF | 13.84 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Median-PS-Value | 0.41 | |||||
| Price-to-Net-Current-Asset-Value | 2.12 | |||||
| Price-to-Net-Cash | 9.51 | |||||
Earnings Yield (Greenblatt) % | -18.52 | |||||
FCF Yield % | 4.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RMTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rockwell Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 69.389 | ||
| EPS (TTM) ($) | -1.34 | ||
| Beta | 1.024 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 68.18 | ||
| 14-Day RSI | 60.94 | ||
| 14-Day ATR ($) | 0.44503 | ||
| 20-Day SMA ($) | 7.818 | ||
| 12-1 Month Momentum % | -55.09 | ||
| 52-Week Range ($) | 4.885 - 18.45 | ||
| Shares Outstanding (Mil) | 4.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rockwell Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rockwell Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 08:00 | In 65 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 06:00 | In 65 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 08:00 | 7.51 (+5.03%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 06:00 | 7.51 (+5.03%) | ||
| 0.1:1 Stock Split | 2026-07-01 | 5.51 (-3.76%) | ||
| General meeting for 2026 | 2026-06-12 10:00 | 6.23 (-6.04%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:00 | 8.10 (-3.57%) | ||
| First quarter earnings results for 2026 | 2026-05-07 06:00 | 8.10 (-3.57%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-26 08:00 | 10.40 (-0.95%) | ||
| Annual report for 2025 | 2026-03-26 | 10.40 (-0.95%) |
Show
Entries
Rockwell Medical Inc Frequently Asked Questions
What is Rockwell Medical Inc(RMTI)'s stock price today?
The current price of RMTI is $7.99. The 52 week high of RMTI is $18.45 and 52 week low is $4.89.
When is next earnings date of Rockwell Medical Inc(RMTI)?
The next earnings date of Rockwell Medical Inc(RMTI) is 2026-11-12 Est..
Does Rockwell Medical Inc(RMTI) pay dividends? If so, how much?
Rockwell Medical Inc(RMTI) does not pay dividend.
Guru Commentaries on NAS:RMTI
Minot Light Capital Partners
Bullish
2026 Q2
What the manager wrote
Rockwell Medical is a compelling investment opportunity due to its unique position in the hemodialysis market, where it holds a duopoly in the U.S. The company is expected to generate positive cash flow and has a reasonable growth outlook. With a current market cap of $25M and an enterprise value of only $10M, the stock is trading at an attractive EV/Sales ratio of 0.14x. If Rockwell executes its plan, revenues could grow from $70M to $100M by 2030, with potential free cash flow of $5-$10M. The recent reverse stock split has created a classic buying opportunity, and we believe the downside is limited while the upside could be substantial.
Press Release
Articles on Rockwell Medical Inc
Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow Turns Positive
Aug 13, 2026
Is Rockwell Medical Inc (RMTI) Undervalued After Q2 Earnings Miss? EPS: -$0.24, Revenue: $17.8M -- GF Score: 46/100
Aug 13, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers